If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEdita Food Regs Regulatory News (EFID)

  • There is currently no data for EFID

EGM minutes

27 Nov 2023 09:54

RNS Number : 7606U
Edita Food Industries S.A.E.
27 November 2023
 

 

 

Edita Food Industries S.A.E- Summary of Resolutions of the Extraordinary General Assembly Meeting of the company convened on Sunday 26 November 2023

Cairo, 26 November 2023

Edita Food Industries SAE ("the Company") announces that the Extraordinary General Assembly Meeting of the Company convened on Sunday 26 November 2023 and resolved the following resolutions by majority:

1. Approved the amendment of the objective of the company and accordingly amend Article (3) of the company's articles of association to read as follows:

 

Article (3) before amendment:

 

The objective of the company shall be:

 

Producing, manufacturing, packaging and wrapping all food products and manufacturing, producing and packaging juices, jams, finished goods and finished dry meals made of dough and manufactured with flour, dairy products, meat, vegetables, fruits, chocolate, natural and vegan cream as well as other required food and ingredients.

 

The company may carry out other projects or amend its objective in accordance with the provisions of the investment law subject to the approval of the General Authority for Investment and Free Zones and without prejudice to the provisions of the laws of the Arab Republic of Egypt, the Company may as well engage or cooperate in any manner whatsoever with different companies regardless their forms.

 

 

Article (3) after amendment:

 

The objective of the company shall be:

 

Producing, manufacturing, packaging and wrapping all food products and manufacturing, producing and packaging juices, jams, finished goods and finished dry meals made of dough and manufactured with flour, dairy products, meat, vegetables, fruits, chocolate, natural and

 

 

 vegan cream as well as other required food and ingredients. The company may carry out toll manufacturing.

 

The company may carry out other projects or amend its objective in accordance with the provisions of the investment law subject to the approval of the General Authority for Investment and Free Zones and without prejudice to the provisions of the laws of the Arab Republic of Egypt, the Company may as well engage or cooperate in any manner whatsoever with different companies regardless their forms.

 

2. Approved the reduction of the capital of the Company from EGP 144,611,687.8 (one hundred forty-four million six hundred eleven thousand six hundred eighty-seven Egyptian pounds and eighty piasters) to EGP 140,002,731.2 (one hundred forty million two thousand seven hundred thirty-one Egyptian pounds and twenty piasters) by way of Cancelling treasury shares of the company in the total of 23,044,783 (twenty-three million forty-four thousand seven hundred eighty-three) shares, each with par value of 0.20 piasters.

 

3. Approved the amendment of Articles (6) and (7) of the articles of association of the Company accordingly to be as follows:

 

Article (6) before amendment:

 

The Company's authorized capital amounts to EGP 360,000,000 (Only Three Hundred Sixty Million Egyptian pounds), and the issued capital shall amount to EGP 144,611,687.80 (Only One Hundred Forty-Four Million Six Hundred Eleven Thousand Six Hundred Eighty-Seven Egyptian pounds and Eighty piasters); divided into 723,058,439 shares; the value of each share is EGP 0.20 (twenty piasters); all of which are cash shares.

 

Article (6) after amendment:

 

The Company's authorized capital amounts to EGP 360,000,000 (Only Three Hundred Sixty Million Egyptian pounds), and the issued capital shall amount to EGP 140,002,731.20 (Only One Hundred Forty-Four Million Two Thousand Seven Hundred Thirty-One Egyptian pounds and twenty piasters); divided into 700,013,656 shares; the value of each share is EGP 0.20 (twenty piasters); all of which are cash shares.

 

 

 

 

Article (7) before amendment:

 

The capital of the company is 723,058,439 shares (seven hundred twenty-three million fifty-eight thousand four hundred thirty-nine shares) and all the shares of the company are nominal shares. The subscription to the capital has been carried out

 

The company's issued capital has been paid by virtue of the annotation at the commercial register. The company's issued capital has been decreased by an amount of EGP 460,892.2, by cancelling the treasury shares at nominal value, amounting to 2,304,461 shares, pursuant to the report No. 1591/2021 issued by the Economic Performance Department based on the company's financial position on 31/12/2021 and accordingly the company's issued share capital, after the decrease, shall be EGP 144,661,687.8 paid in full.

 

Article (7) after amendment:

 

The capital of the company is 700,013,656 shares (seven hundred million thirteen thousand six hundred fifty-six shares) and all the shares of the company are nominal shares. The subscription to the capital has been carried out.

 

The company's issued capital has been paid by virtue of the annotation at the commercial register. The company's issued capital has been decreased by an amount of EGP 4,608,956.6, by cancelling the treasury shares at nominal value, amounting to 23,044,783 shares, pursuant to the report No. 2486 of 2023 issued by the Economic Performance Department based on the company's financial position on 30 June 2023 and accordingly the company's issued share capital, after the decrease, shall be EGP 140,002,731.2 paid in full.

 

 

Ends

Contacts

Ms. Menna Shams El Din

Head of Investor Relations and Corporate Affairs

T: +202 3851 6464 | M: +20 100 1542428 |  menna.shamseldin@edita.com.eg

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STREANFXASFDFEA
Date   Source Headline
2nd Nov 20213:45 pmRNSEdita's Results- 3Q2021
2nd Nov 20213:41 pmRNSEdita's Board Resolution- 3Q2021
1st Nov 20217:00 amRNSTwinkies higher price point introduction at EGP3
25th Oct 202110:12 amRNSEdita raises price points across Molto products
2nd Aug 20212:32 pmRNSEdita's Summary of Board Resolutions- 2Q2021
2nd Aug 20212:26 pmRNSEdita Announces 2Q2021/1H2021 Results
10th May 20212:19 pmRNS1Q2021 Financial Statements & Earnings Release
10th May 20212:02 pmRNSResolutions of BoD Meeting 10 May 2021
7th Apr 20218:18 amRNSAnnouncement on Dividend Distribution
6th Apr 20217:00 amRNSEdita's EGM Summary of Resolutions
1st Apr 20213:00 pmRNSEdita's EGM invitation
31st Mar 20218:43 amRNSSummary of Resolutions of OGM, 30 March 2021
30th Mar 20217:00 amRNSEdita signs a new medium term loan
11th Mar 20217:46 amRNSEdita's EGM Invitation
8th Mar 20218:28 amRNSEdita's OGM Invitation
24th Feb 20213:23 pmRNSEdita Food Industries Reports FY2020 Earnings
24th Feb 20213:00 pmRNSSummary of BoD Resolutions 24 Feb. 2021
8th Feb 20217:00 amRNSEdita installs new wafer line
31st Dec 202012:40 pmRNSSecond Price Monitoring Extn
31st Dec 202012:35 pmRNSPrice Monitoring Extension
10th Nov 20202:32 pmRNSEdita 3Q2020 Financial Results & Earnings Release
10th Nov 20202:28 pmRNSBoard of directors decisions 10 November 2020
13th Oct 20209:50 amRNSDisclosure regarding a dispute
22nd Sep 20208:43 amRNSLoan announcement
28th Jul 20203:45 pmRNSEdita 2Q2020 Financial Results
28th Jul 20203:42 pmRNSEdita Board of Directors meeting 28July20
29th Jun 20201:42 pmRNSMorocco Loan Announcement
4th Jun 20202:14 pmRNSTreasury Shares program
20th May 20208:49 amRNSEdita Enters the Biscuits Segment
12th May 20209:27 amRNSEdita's 1Q2020 Earnings Release
12th May 20209:14 amRNSResolutions of BoD Meeting on May 11
22nd Apr 202012:07 pmRNSSecond Price Monitoring Extn
22nd Apr 202012:02 pmRNSPrice Monitoring Extension
7th Apr 20208:45 amRNSAnnouncement on Dividend Distribution
6th Apr 20201:08 pmRNSResolutions of BoD meeting 5th of April
6th Apr 20207:00 amRNSLoan Announcement
31st Mar 202010:31 amRNSAGM Statement
26th Mar 20208:41 amRNSAudited Consolidated IFRS Statements 2019
5th Mar 20208:16 amRNSEdita OGM invitation
27th Feb 20207:20 amRNSBoard of Directors meeting decisions 26 feb 2020
26th Feb 20205:02 pmRNSEdita Earnings Release 2019
26th Feb 20204:52 pmRNSIFRS Financial Statements 2019
26th Feb 20204:15 pmRNSEdita Financial Results
26th Feb 20203:18 pmRNSBoard of Directors meeting decisions 26 Feb 2020
30th Oct 20192:50 pmRNSEdita 3Q2019 Edita financial Results
30th Oct 20192:15 pmRNSBoard of Directors change
30th Oct 20192:07 pmRNSEdita BOD decisions 30 October 2019
21st Oct 20197:00 amRNSEdita receives a MAD15million grant
30th Jul 20195:08 pmRNS2Q2019 Audited Financial Results
30th Jul 20194:55 pmRNSBoard of directors decisions 30 July 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.